ITOS

iTeos Therapeutics, Inc.

Sales chart range
Log in to watch ITOS
Latest sale
$1M
Jun 10 · Routine
Form 4 sales
95
On record
Form 144 notices
1
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 144 noticeNotice
    Aug 23 2023

    Filed to sell 350,000 shares ($4.1M)

    Boxer Capital, LLC, Seller's CEO is Director of Issuer

    No 10b5-1 planFiling

  2. 2 Form 4 saleNo plan
    Aug 23 same day

    Sold 350,000 shares at $16.26 ($5.7M)

    Davis Aaron I., Other

    No 10b5-1 planSold 16.2% of holdings ($35M position)1.8M shares leftFiling

  3. 3 Form 4 saleNo plan
    May 13 +629 days

    Sold 630,191 shares at $8.06 ($5.1M)

    Mpm Bioventures 2018 (b), L.P., Other

    No 10b5-1 planSold 23% of holdings ($22.1M position)2.1M shares leftFirst sale on recordFiling

  4. 4 Form 4 saleNo plan
    May 13 same day

    Sold 630,191 shares at $8.06 ($5.1M)

    MPM BioVentures 2018 GP LLC, Other

    No 10b5-1 planSold 23% of holdings ($22.1M position)2.1M shares leftFirst sale on recordFiling

  5. 5 Form 4 saleNo plan
    May 13 same day

    Sold 1M shares at $8.06 ($8.3M)

    MPM BioImpact LLC, Other

    No 10b5-1 planSold 23% of holdings ($36.1M position)3.5M shares leftFirst sale on recordFiling

  6. 6 Form 4 saleRoutine
    Jun 6 +24 days

    Sold 114,682 shares at $10.15 ($1.2M)

    Hallal David, Director

    10b5-1 planSold 100% of holdings ($1.2M position)0 shares leftFirst sale on recordFiling

  7. 7 Form 4 saleRoutine
    Jun 6 same day

    Sold 156,847 shares at $10.15 ($1.6M)

    Detheux Michel, Chief Executive Officer

    10b5-1 planSold 53.6% of holdings ($3M position)135,903 shares leftFirst sale on recordFiling

  8. 8 Form 4 saleRoutine
    Jun 10 +4 days

    Sold 104,565 shares at $10.02 ($1M)

    Detheux Michel, Chief Executive Officer

    10b5-1 planSold 43.5% of holdings ($2.4M position)135,903 shares leftFiling

Every transaction

Loading transactions…

Sales, notices and lockups (96)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for ITOS
Source
Jun 10, 2025Detheux MichelChief Executive OfficerForm 4 sale104,565$1M43.5%RoutineSEC
Jun 6, 2025Detheux MichelChief Executive OfficerForm 4 sale156,847$1.6M53.6%RoutineSEC
Jun 6, 2025Hallal DavidDirectorForm 4 sale114,682$1.2M100.0%RoutineSEC
May 13, 2025MPM BioImpact LLCOtherForm 4 sale1M$8.3M23.0%No planSEC
May 13, 2025MPM BioVentures 2018 GP LLCOtherForm 4 sale630,191$5.1M23.0%No planSEC
May 13, 2025Mpm Bioventures 2018 (b), L.P.OtherForm 4 sale630,191$5.1M23.0%No planSEC
Aug 23, 2023Davis Aaron I.OtherForm 4 sale350,000$5.7M16.2%No planSEC
Aug 23, 2023Boxer Capital, LLCSeller's CEO is Director of IssuerForm 144 notice350,000$4.1MNoticeSEC
Jun 9, 2022Hallal DavidDirectorForm 4 sale29,615$597k100.0%UnusualSEC
May 11, 2022Davis Aaron I.DirectorForm 4 sale663,000$14M23.5%Plan not statedSEC
May 2, 2022Davis Aaron I.DirectorForm 4 sale375,000$10.2M11.7%Plan not statedSEC
Apr 18, 2022Detheux MichelChief Executive OfficerForm 4 sale11,500$367k30.5%UnusualSEC
Mar 22, 2022Detheux MichelChief Executive OfficerForm 4 sale18,437$630k41.2%UnusualSEC
Mar 17, 2022Boxer Capital, LLC10% ownerForm 4 sale575,201$20.3M15.5%Plan not statedSEC
Mar 11, 2022Lager Joanne JenkinsChief Medical OfficerForm 4 sale3,500$126k100.0%UnusualSEC
Mar 1, 2022McGrath YvonneChief Scientific OfficerForm 4 sale10,000$368k100.0%UnusualSEC
Feb 23, 2022Detheux MichelChief Executive OfficerForm 4 sale14,500$498k29.5%UnusualSEC
Feb 11, 2022Lager Joanne JenkinsChief Medical OfficerForm 4 sale3,500$125k100.0%UnusualSEC
Jan 25, 2022Detheux MichelChief Executive OfficerForm 4 sale14,500$517k22.8%Plan not statedSEC
Jan 14, 2022Lager Joanne JenkinsChief Medical OfficerForm 4 sale3,500$138k100.0%UnusualSEC
Jan 5, 2022MPM BioVentures 2018 GP LLC10% ownerForm 4 sale146,685$6.2M5.1%UnusualSEC
Jan 5, 2022Mpm Asset Management Investors Bv2018 LLC10% ownerForm 4 sale146,685$6.2M5.1%Plan not statedSEC
Jan 5, 2022Gadicke Ansbert10% ownerForm 4 sale245,469$10.5M5.2%UnusualSEC
Jan 4, 2022MVA Investors, LLC10% ownerForm 4 sale700,000$32.6M100.0%UnusualSEC
Jan 3, 2022Lager Joanne JenkinsChief Medical OfficerForm 4 sale7,000$363k100.0%UnusualSEC
Jan 3, 2022Biniszkiewicz DetlevDirectorForm 4 sale3,500$182k100.0%UnusualSEC
Dec 27, 2021Gall MatthewChief Financial OfficerForm 4 sale5,000$232k25.7%UnusualSEC
Dec 22, 2021Detheux MichelChief Executive OfficerForm 4 sale44,500$2M41.1%UnusualSEC
Dec 20, 2021Hallal DavidDirectorForm 4 sale50,000$2.2M100.0%UnusualSEC
Dec 17, 2021Lager Joanne JenkinsChief Medical OfficerForm 4 sale7,000$287k100.0%UnusualSEC
Dec 10, 2021Lager Joanne JenkinsChief Medical OfficerForm 4 sale3,500$121k100.0%UnusualSEC
Dec 7, 2021Mpm Bioventures 2018, L.P.10% ownerForm 4 sale49,831$1.7M1.7%Plan not statedSEC
Dec 7, 2021Mpm Bioventures 2018 (b), L.P.10% ownerForm 4 sale49,831$1.7M1.7%Plan not statedSEC
Dec 7, 2021Oncology Impact Fund (Cayman) Management L.P.10% ownerForm 4 sale83,390$2.8M1.7%Plan not statedSEC
Dec 2, 2021MPM BioVentures 2018 LLC10% ownerForm 4 sale83,519$2.9M2.8%Plan not statedSEC
Dec 2, 2021Evnin Luke10% ownerForm 4 sale83,519$2.9M2.8%Plan not statedSEC
Dec 2, 2021BioImpact Capital LLC10% ownerForm 4 sale139,773$4.8M2.8%UnusualSEC
Nov 29, 2021MPM BioVentures 2018 LLC10% ownerForm 4 sale23,045$811k0.8%Plan not statedSEC
Nov 29, 2021Mpm Bioventures 2018 (b), L.P.10% ownerForm 4 sale23,045$811k0.8%Plan not statedSEC
Nov 29, 2021Oncology Impact Fund (Cayman) Management L.P.10% ownerForm 4 sale38,566$1.4M0.8%Plan not statedSEC
Nov 24, 2021Oncology Impact Fund (Cayman) Management L.P.10% ownerForm 4 sale129,617$4.7M2.5%Plan not statedSEC
Nov 24, 2021MPM BioVentures 2018 LLC10% ownerForm 4 sale77,455$2.8M2.5%Plan not statedSEC
Nov 24, 2021Evnin Luke10% ownerForm 4 sale77,455$2.8M2.5%Plan not statedSEC
Nov 23, 2021Detheux MichelChief Executive OfficerForm 4 sale14,500$523k15.6%Plan not statedSEC
Nov 18, 2021Lager Joanne JenkinsChief Medical OfficerForm 4 sale28,000$966k100.0%UnusualSEC
Nov 3, 2021Detheux MichelChief Executive OfficerForm 4 sale20,557$587k21.2%Plan not statedSEC
Oct 21, 2021Detheux MichelChief Executive OfficerForm 4 sale196$5k0.2%Plan not statedSEC
Oct 19, 2021Detheux MichelChief Executive OfficerForm 4 sale1,836$51k1.9%Plan not statedSEC
Oct 18, 2021MPM BioVentures 2018 GP LLC10% ownerForm 4 sale17,099$469k0.5%Plan not statedSEC
Oct 18, 2021MPM BioVentures 2014, L.P.10% ownerForm 4 sale17,099$469k0.5%Plan not statedSEC
Oct 18, 2021Oncology Impact Fund (Cayman) Management L.P.10% ownerForm 4 sale28,615$785k0.6%Plan not statedSEC
Oct 14, 2021MPM BioVentures 2018 GP LLC10% ownerForm 4 sale56,770$1.5M1.8%Plan not statedSEC
Oct 14, 2021MPM BioVentures 2014, L.P.10% ownerForm 4 sale56,770$1.5M1.8%Plan not statedSEC
Oct 14, 2021Gadicke Ansbert10% ownerForm 4 sale95,002$2.6M1.8%Plan not statedSEC
Oct 11, 2021Mpm Bioventures 2018, L.P.10% ownerForm 4 sale51,993$1.4M1.6%Plan not statedSEC
Oct 11, 2021Foley Todd10% ownerForm 4 sale51,993$1.4M1.6%Plan not statedSEC
Oct 11, 2021Oncology Impact Fund (Cayman) Management L.P.10% ownerForm 4 sale87,006$2.4M1.6%Plan not statedSEC
Oct 4, 2021Mpm Bioventures 2018, L.P.10% ownerForm 4 sale27,566$746k0.8%Plan not statedSEC
Oct 4, 2021Evnin Luke10% ownerForm 4 sale27,566$746k0.8%Plan not statedSEC
Oct 4, 2021Gadicke Ansbert10% ownerForm 4 sale46,130$1.2M0.9%Plan not statedSEC
Sep 30, 2021MPM BioVentures 2018 GP LLC10% ownerForm 4 sale21,506$581k0.6%Plan not statedSEC
Sep 30, 2021MPM BioVentures 2014 LLC10% ownerForm 4 sale21,506$581k0.6%Plan not statedSEC
Sep 30, 2021BioImpact Capital LLC10% ownerForm 4 sale35,990$972k0.7%Plan not statedSEC
Sep 27, 2021MPM BioVentures 2018 GP LLC10% ownerForm 4 sale53,468$1.5M1.6%Plan not statedSEC
Sep 27, 2021Evnin Luke10% ownerForm 4 sale53,468$1.5M1.6%Plan not statedSEC
Sep 27, 2021UBS Oncology Impact Fund L.P.10% ownerForm 4 sale89,476$2.5M1.6%Plan not statedSEC
Sep 24, 2021Detheux MichelChief Executive OfficerForm 4 sale6,411$180k6.1%Plan not statedSEC
Sep 22, 2021Mpm Bioventures 2018, L.P.10% ownerForm 4 sale33,929$933k1.0%Plan not statedSEC
Sep 22, 2021MPM Asset Management Investors BV2014 LLC10% ownerForm 4 sale33,929$933k1.0%Plan not statedSEC
Sep 22, 2021Gadicke Ansbert10% ownerForm 4 sale56,779$1.6M1.0%Plan not statedSEC
Sep 20, 2021Foley Todd10% ownerForm 4 sale91,254$2.6M2.6%Plan not statedSEC
Sep 20, 2021MPM BioVentures 2018 GP LLC10% ownerForm 4 sale91,254$2.6M2.6%Plan not statedSEC
Sep 20, 2021Oncology Impact Fund (Cayman) Management L.P.10% ownerForm 4 sale152,711$4.3M2.7%Plan not statedSEC
Sep 15, 2021MPM BioVentures 2014, L.P.10% ownerForm 4 sale45,665$1.3M1.3%Plan not statedSEC
Sep 15, 2021MPM BioVentures 2018 GP LLC10% ownerForm 4 sale45,665$1.3M1.3%Plan not statedSEC
Sep 15, 2021Gadicke Ansbert10% ownerForm 4 sale76,417$2.1M1.3%Plan not statedSEC
Sep 13, 2021BioImpact Capital LLC10% ownerForm 4 sale96,456$2.7M1.6%Plan not statedSEC
Sep 13, 2021Evnin Luke10% ownerForm 4 sale57,640$1.6M1.6%Plan not statedSEC
Sep 13, 2021MPM BioVentures 2018 GP LLC10% ownerForm 4 sale57,640$1.6M1.6%Plan not statedSEC
Sep 8, 2021Oncology Impact Fund (Cayman) Management L.P.10% ownerForm 4 sale71,232$2.1M1.2%Plan not statedSEC
Sep 8, 2021Mpm Bioventures 2018 (b), L.P.10% ownerForm 4 sale42,566$1.2M1.2%Plan not statedSEC
Sep 8, 2021Mpm Bioventures 2018, L.P.10% ownerForm 4 sale42,566$1.2M1.2%Plan not statedSEC
Sep 2, 2021Detheux MichelChief Executive OfficerForm 4 sale20,252$581k16.1%Plan not statedSEC
Aug 31, 2021Detheux MichelChief Executive OfficerForm 4 sale14,663$412k10.4%Plan not statedSEC
Aug 25, 2021Detheux MichelChief Executive OfficerForm 4 sale8,585$241k5.8%Plan not statedSEC
Jun 14, 2021Detheux MichelChief Executive OfficerForm 4 sale29,000$826k16.3%Plan not statedSEC
Jun 8, 2021McGrath YvonneVP, Research and DevelopmentForm 4 sale7,927$159k100.0%UnusualSEC
Jun 2, 2021McGrath YvonneVP, Research and DevelopmentForm 4 sale7,927$160k100.0%UnusualSEC
May 24, 2021McGrath YvonneVP, Research and DevelopmentForm 4 sale7,927$174k100.0%UnusualSEC
May 17, 2021McGrath YvonneVP, Research and DevelopmentForm 4 sale7,926$196k100.0%UnusualSEC
Apr 9, 2021MPM BioVentures 2014, L.P.10% ownerForm 4 sale119$4k0.0%Plan not statedSEC
Apr 9, 2021MPM BioVentures 2018 GP LLC10% ownerForm 4 sale119$4k0.0%Plan not statedSEC
Apr 9, 2021MPM Oncology Impact Management LP10% ownerForm 4 sale200$6k0.0%Plan not statedSEC
Apr 8, 2021MPM Oncology Impact Management LP10% ownerForm 4 sale41,982$1.3M0.7%Plan not statedSEC
Apr 8, 2021Mpm Asset Management Investors Bv2018 LLC10% ownerForm 4 sale25,087$777k0.7%Plan not statedSEC
Apr 8, 2021MPM BioVentures 2018 GP LLC10% ownerForm 4 sale25,087$777k0.7%Plan not statedSEC